Ian T.
Cousins
*a,
Jamie C.
De Witt
b,
Juliane
Glüge
c,
Gretta
Goldenman
d,
Dorte
Herzke
e,
Rainer
Lohmann
f,
Mark
Miller
g,
Carla A.
Ng
h,
Sharyle
Patton
i,
Martin
Scheringer
cj,
Xenia
Trier
k and
Zhanyun
Wang
l
aDepartment of Environmental Science, Stockholm University, SE-10691 Stockholm, Sweden. E-mail: ian.cousins@aces.su.se
bEast Carolina University, Brody School of Medicine, Department of Pharmacology and Toxicology, Greenville, NC 27834, USA
cInstitute of Biogeochemistry and Pollutant Dynamics, ETH Zürich, 8092 Zürich, Switzerland
dMilieu Consulting SPRL, Brussels, Belgium
eNorwegian Institute for Air Research (NILU), 9296 Tromsø, Norway
fGraduate School of Oceanography, University of Rhode Island, Narragansett, Rhode Island 02882, USA
gNational Institute of Environmental Health Sciences, U.S. Public Health Service, Research Triangle Park, NC, USA
hDepartment of Civil & Environmental Engineering and Environmental and Occupational Health, University of Pittsburgh, Pittsburgh, PA, USA
iHealth and Environment Program Commonweal, CA, USA
jRECETOX, Masaryk University, 625 00 Brno, Czech Republic
kEuropean Environment Agency, Kgs. Nytorv 6, DK-1050 Copenhagen K, Denmark
lChair of Ecological Systems Design, Institute of Environmental Engineering, ETH Zürich, 8093 Zürich, Switzerland
First published on 23rd June 2021
The essential-use concept is a tool that can guide the phase-out of per- and polyfluoroalkyl substances (PFAS) and potentially other substances of concern. This concept is a novel approach to chemicals management that determines whether using substances of concern, such as PFAS, is truly essential for a given functionality. To assess the essentiality of a particular use case, three considerations need to be addressed: (1) the function (chemical, end use and service) that the chemical provides in the use case, (2) whether the function is necessary for health and safety and critical for the functioning of society and (3) if the function is necessary, whether there are viable alternatives for the chemical for this particular use. A few illustrative examples of the three-step process are provided for use cases of PFAS. The essential-use concept takes chemicals management away from a substance-by-substance approach to a group approach. For PFAS and other substances of concern, it offers a more rapid pathway toward effective management or phase-out. Parts of the concept of essential use have already been widely applied in global treaties and international regulations and it has also been recently used by product manufacturers and retailers to phase out substances of concern from supply chains. Herein some of the common questions and misinterpretations regarding the practical application of the essential-use concept are reviewed, and answers and further clarifications are provided.
Environmental significanceCurrent chemicals management typically relies on risk-based approaches, whereby society performs chemical-by-chemical risk assessments on those chemicals of highest concern, and only those chemicals with demonstrated risks are regulated. Experience has shown, however, that such a time- and resource-intensive risk-based approach is impractical, given the vast numbers of chemicals in use and lack of information on most of them. The concept of essential use argues for a more holistic approach to assessing the use of substances of concern, by asking whether those substances, such as PFAS, are functionally necessary within a given product or manufacturing process. It is argued that substances of concern should only be used if their use is considered essential for health and safety or critical to the functioning of society. If alternatives (i.e. different products, materials or chemicals) exist on the market or have been invented, the use of these substances of concern is also non-essential, and can be phased out, though alternatives assessment might be needed. The concept of essential use is not limited to be used by regulators, but can also be used by retailers and manufacturers that aim to reduce their chemical footprint. |
The concept of essential use came up in global discussions concerning how to restrict ozone-depleting substances as early as 1977, well before the adoption of the 1987 Montreal Protocol.3 The Montreal Protocol codifies the global consensus that a comprehensive phase-out of the production and use of ozone depleting substances is needed to preserve the ozone layer. However, it allows parties to put forward applications for exemptions for those uses considered essential at a national level.
Since the publication of the 2019 paper,1 there has been a large interest and response. The European Commission was strongly supportive2,4 and has incorporated the concept in its recently published Chemicals Strategy for Sustainability2 adopted on 14 October 2020. On the other hand, there has also been strong criticism of the essential-use concept within the chemical industry. Some of these criticisms were recently presented in an article published by Chemical Watch5 and a statement from the American Chamber of Commerce (AmCham).6 In our opinion, these criticisms reveal a lack of understanding of the concept, and sometimes misinterpret the concept. Here, we (1) show that similar decision tools to the essential-use concept are already widely applied in global treaties and international regulations, (2) illustrate the application of the essential-use concept for a few case studies, and (3) answer frequent questions, and deal with common misinterpretations, regarding the essential-use concept.
In REACH, the use of chemicals may be regulated through authorisation or restriction, for which exemptions (often referred to as derogations) may be considered. For authorisation, companies may apply for continued use of the listed substance after the sunset date, either by demonstrating that the risk from using the substance is adequately controlled (adequate control route), or by demonstrating that the socioeconomic benefits of using the substance outweigh the risks and that there are no suitable alternative substances or technologies for the applicant (socio-economic analysis route). For restriction, exemptions are considered during the preparation or the evaluation of the restriction proposal, including a socio-economic analysis. The socio-economic analysis for both authorisation and restriction follows a list of factors that may be taken into account (without excluding any other factors that could be preferred) as specified in REACH Annex XVI. This includes impacts on industry, consumers, job security and employment, and trade, competition and economic development; possible benefits for human health and the environment (and the social and economic benefits, in the case of restriction) and availability, suitability and technical feasibility of alternative substances and/or technologies and economic consequences thereof.
Under the Stockholm Convention, when deciding whether to list a chemical in Annex A (elimination) or Annex B (restriction), the Conference of the Parties (COP) may also decide certain uses to be exempted from the convention obligations. Unlike the Montreal Protocol, the convention does not explicitly specify how exemptions would be decided with which criteria, but only requests specific information to be considered (as specified in Annex F). This includes efficacy and efficiency of possible control measures in meeting risk reduction goals, alternatives, positive and/or negative impacts on society of implementing possible control measures, waste and disposal implications, access to information and public education, status of control and monitoring capacity, and any national or regional control actions taken. There are two types of exemptions, i.e. specific exemptions (time limited; for substances listed in Annex A or B) and Acceptable Purposes (time unlimited; for substances listed in Annex B only). Parties to the Convention must register specific exemptions or acceptable purposes, but no justification is needed. The registration of specific exemptions expires automatically after a period of five years, and Parties may apply for an extension, but with a justification of the continuing need for registration of that exemption. To date, no countries have applied for any extension of specific exemptions.
In the EU Biocides Regulation, biocidal active ingredients that fall within the hazard-based “cut-off criteria” for non-approval (i.e., CMR (carcinogenic, mutagenic or toxic to reproduction), PBT (persistent, bioaccumulative and toxic), vPvB (very persistent and very bioaccumulative), or have endocrine-disrupting properties) cannot be approved unless shown to be “essential to prevent or control a serious danger to human health, animal health or the environment” or if there is a “disproportionate negative impact on society when compared with the risk to human health, animal health or the environment”. There are no references to safety or the functioning of society.
(1) “Non-essential” uses are defined as those driven by convenience and business opportunities and that are “nice to have” rather than having a function that is critical for health and safety, and the functioning of society. An example of a non-essential use of PFAS is their use in providing improved glide to skis through the application of fluorinated ski waxes. PFAS-containing ski waxes may help the skier ski faster compared to when using conventional non-fluorinated ski waxes, but the ability to ski faster is not considered an aspect of health and safety, and the functioning of society. For “non-essential” uses, a phase-out via a ban or restriction of PFAS can be prepared (e.g. as in the case of the use of PFAS-containing ski waxes in ski racing11) without having to conduct time-consuming and costly Chemical Alternatives Assessment (CAA).12–14
(2) For so-called “substitutable” uses, the substance of concern does have a function necessary for health, safety or critical for the functioning of society, but its use is considered unnecessary because there are suitable alternatives available. Not all substitutions require direct replacements of a substance of concern with a safer and sustainable chemical alternative; a non-chemical (engineering) innovation can be equally successful and may be encouraged/prioritized over chemical alternatives. For “substitutable” uses, it is important to ensure that the alternatives do not lead to “regrettable substitutions” that lead to “problem shifting” (i.e. removing one problem chemical and replacing it with another that is similarly or even more troublesome) and this requires the implementation of CAA.12–14 The use of PFAS in fire-fighting foams, used for extinguishing fuel fires at commercial airports, is an example of a “substitutable use”.15 The so-called fluorine-free foams (3F)16 have replaced aqueous film-forming foams (AFFF) for extinguishing fuel fires at commercial airports around the world.
(3) Finally, some uses of substances of concern will be considered “essential” uses because the substance of concern has a function necessary for health, safety or critical for the functioning of society and because there are currently no alternatives. A current example may be the use of PFAS in surgical gowns to provide repellency against a wide range of liquids of different polarities, as well as viruses and bacteria, and to provide breathability of fabrics during long operations.17 For identified “essential uses”, while phase-out is not currently possible, mechanisms need to be implemented to allow eventual transition to safer alternatives. These could include time limits or “sunsets” of a few years set for re-evaluation of alternatives on a regular basis. In the meantime, innovation in the development of safe and sustainable alternatives should be stimulated through, e.g., market incentives, Green Chemistry funding, as well as demand from the public and non-governmental organizations (NGOs). Knowing that once an alternative is developed the substance of concern will be phased out will also drive innovation from the industry sector.
To assess the essentiality of a particular use case and to determine which of the above three categories applies, one needs to consider the following three aspects, in a stepwise manner: (Aspect 1) the function (see definition of “function” below) that the substance of concern provides in the use case, (Aspect 2) whether the function is necessary for health and safety and critical for the functioning of society and (Aspect 3) if the function is necessary, whether there are viable alternatives for the chemical for this particular use. A use of a substance of concern can be considered as “non-essential” when either Aspect 2 is determined to be negative or Aspects 2 and 3 are determined to be positive.
This three-step procedure follows the concept of “functional substitution”. When evaluating function under Aspects 2 and 3, one should consider the essentiality of the “chemical function”, “end-use function”, and “service function”, although these different categories of function are not always easily defined and separated.18
When assessing the essentiality of the chemical function, an evaluator considers, for example, whether the chemical function and performance provided by the chemical is necessary (Aspect 2) and, if that is the case, whether there is an alternative chemical/technology that can provide adequate function and performance (Aspect 3). Similar questions can be asked for the end-use function, i.e. the evaluator asks if the end-use function is needed and, if that is the case, asks whether the end-use function can be replaced by an alternative material, product, or process. In the case of the service function, the evaluator considers whether the service function provided by the chemical is needed, and if that is the case, asks whether the service function can be replaced through system change. The use of a substance of concern would therefore only be considered essential if it was needed on all three functional levels. Functional substitution is described more fully with examples by Tickner et al.18 Below are a few brief examples to illustrate the application of the concept to PFAS.
Identifying certain chemicals as “essential” could also be problematic for society because it would lead to the existence of technological monopolies for the economic services provided by the use of a certain chemical or group of chemicals and inhibit innovation. If society then became overly dependent on a chemical or group of chemicals that later were proven to be of concern, it would prove challenging to rapidly phase out these chemicals to eliminate the hazard. History provides many examples of chemicals thought to be essential or indispensable, even though they carried tremendous health and environmental concerns. For example, methyl bromide was long exempted from phase out under the Montreal Protocol as it was wrongly considered indispensable in agricultural production despite serious concerns regarding its ability to deplete stratospheric ozone.27
Innovation is key for the development of new materials, free from substances of concern. The essential-use concept will therefore not curtail innovation, but rather channel innovation in the direction of achieving a ‘toxic-free environment’ and a society where the harm from chemicals and products is minimised.2 This innovation is desired by consumers, as evidenced in calls for greater transparency28 and fewer ingredients29 (in e.g. personal care products). In the case of uses of PFAS, many PFAS-free alternatives for a variety of use cases have been developed in recent years (e.g. fire-fighting foams,16 food-contact materials and textiles19) due to societal pressure on this class of substances. The phase-out of substances of concern, or the threat of it, has been shown to stimulate innovation to develop new chemicals, materials and alternative solutions.30 A good example of recent innovation in a collaborative form is within the Swedish POPFREE-project, in which a group of small companies have collaborated to develop alternatives to PFAS for grease-resistant paper, textile and leather treatment, cosmetics, film-forming agents, and fire-fighting foam.25 Retailers are also increasingly requesting PFAS-free products from their suppliers (e.g. Nordic Coop,31 IKEA32 and H&M33), ensuring increased market shares for the developers of innovative products and materials.
In fact, the concept of essential use is exactly not needed for chemicals with already identified unacceptable risks, because actions should already be in place to phase out these chemicals. Rather, it is particularly useful for application to chemical classes such as PFAS, which contain thousands of substances, the majority of which have not undergone detailed toxicological assessment, yet all have one or more problematic intrinsic properties.
Although there may not be consensus on what is considered a “substance of concern” or class of substances of concern, the essential-use concept is flexible and can be applied to a broad range of chemistries. Application of the essential-use concept on a class basis would avoid unnecessary exposure of humans and the environment to a whole class of chemicals. This is also articulated in the Chemicals Strategy for Sustainability of the EU,2 for example in Section 2.3.1 “move away from assessing and regulating chemicals substance-by-substance to regulating them by groups”. The essential-use concept is intended for managing “substances of concern” because for these substances a speedy replacement and/or effective mitigation measures are particularly important.
Technical performance standards can unfortunately also require the use of substances of concern without scientific justification, and may create technical lock-ins that inhibit their phase-out. For example, in the US, concern over fires caused by cigarettes led to a flammability standard for the polyurethane foam used in upholstered furniture. The most cost-effective way to achieve the standard was by the addition of high levels of hazardous organohalogen flame retardant chemicals to the foam. Efforts to change the standard due to concerns regarding the human and environmental health effects associated with the flame retardants were impeded by the manufacturers of the flame retardants for years. Eventually a new standard was developed that ensured fire safety without the addition of harmful chemicals. This resulted in the lowering of indoor air/dust concentrations of flame retardants.35
Another example of a standard inhibiting the phase out of PFAS is the U.S. Department of Defense (DOD) military specification (referred to as “Mil-Spec”) that required the firefighting foams used for extinguishing Class-B fuel fires to contain fluorine or have positive spreading coefficients necessary for film-formation.16 The Mil-Spec standard was also extended to civilian airports by the US Federal Aeronautics Agency. Over the past couple of decades, fluorine-free foams (3F) were developed that matched the performance of many AFFF in extinguishing fuel fires. However, because they did not contain fluorine, they could not achieve Mil-Spec approval. Due to recent legislation enacted by the US Congress, civilian airports and DOD installations are no longer required to use fluorinated AFFFs. The use of fluorinated AFFFs has left a legacy of hundreds of instances of PFAS contamination of groundwater and drinking water across the United States36 and elsewhere.
The view that it is highly subjective to determine which uses are essential or not was put forward in a recently published commentary written by a representative of the chemical industry.5 The COVID-19 global pandemic was used in the commentary as an illustrative case to point out that different countries come to different decisions on what are essential and non-essential human and commercial activities during extraordinary circumstances such as pandemics. It has further been argued that if society had determined that the use of PFAS in personal protective equipment (PPE) was non-essential before the COVID-19 pandemic, it would have left humanity vulnerable to COVID-19. In other words, the pandemic has been used to illustrate that there can be regional and temporal variations in essentiality.
The EU Plant Protection Products Regulation (PPPR)37 is an example of regional differences concerning what might be considered essential. Under the PPPR, approval of an active substance takes place at the EU level, after the substance has been assessed to make sure it meets certain criteria. Authorization of the formulations (‘products’) using the approved active substance, on the other hand, takes place at the Member State level. To ensure the free movement of goods within the EU and reduce administrative burdens, the PPPR applies the principle of mutual recognition, under which authorizations granted by one Member State are to be accepted by other Member States. During the legislative process, this principle of mutual recognition was strongly resisted by the Nordic countries, because of differences in geographical conditions with e.g. the Mediterranean countries. The impasse was resolved by dividing the EU into three geographical zones with comparable agricultural, plant health and climatic conditions that are key factors regarding the presence of pests and in pesticide degradation, i.e., North, Centre and South. The principle of mutual recognition applies within each zone, but not across zones. Although it is likely that regional differences in the perceptions of essentiality of a use will exist, this does not preclude the use of the essential-use concept as a tool to guide the phase-out of substances of concern.
With regard to temporal variations in essentiality, it is hoped that for uses for which a substance of concern is still essential today, more sustainable alternatives will be developed in the near future and the substance of concern will no longer be needed. On the other hand, cases where substances of concern are non-essential today and essential tomorrow are likely to be rare but are possible (e.g. due to a sudden increase in malaria in a region or during another unforeseen pandemic). Fortunately, chemical legislation often contains a clause on emergency approval for chemicals. Therefore, when special circumstances arise, exceptions could be made, but this does not justify the non-essential use of substances of concern outside of times of crisis.
A recent discussion paper for CARACAL (Competent Authorities for REACH and CLP)4 discusses possibilities for applying the essential-use concept within EU chemicals regulation. The paper points to the lack of reliable and specific information on the costs and benefits of each particular use of an SVHC, a problem frequently confronting those preparing an authorization or restriction dossier. It suggests that the concept of essential use could enable a faster processing of authorization and restriction dossiers, by taking into consideration the essentiality of a particular use early on.
Notably, a version of the essential-use concept is already integrated in China in the newest version of the new chemical registration law that entered into force on 1 January 2021, in a different direction from the considerations under REACH as stated in the CARACAL discussion paper.38 In particular, it specifies that for highly hazardous substances (i.e., PBT or vPvB substances, or substances of equivalent concern to the environment or human health), registrants must submit information on socio-economic benefits of the chemicals to fully justify the necessity of the intended activities (e.g. research, production, import, processing and use). The socio-economic benefit analysis includes whether the new chemical substances are equivalent to or have obvious advantages over the substitutes that are in use in terms of aspects such as performance and environmental friendliness. The registration will be evaluated by an expert committee and competent authorities; if rejected, then the chemical cannot be used in the intended activities in China. Along with the new chemical registration law, an implementation guidance, including detailed requirements of the socio-economic analysis, has also been published.39
There is a possibility, however, that there may be a lack of information on hazardous intrinsic properties for some alternatives that could add uncertainty to the substitution process. For example, brominated flame retardants were replaced with supposedly safer organophosphate ester flame retardants, but little was known about these alternatives and research projects were needed to fill data gaps.40 Now evidence is mounting that these alternatives are also problematic.41
An example for PFAS is the case of replacing PFAS-containing products for durable water repellency in textiles with PFAS-free alternatives. It was found that is some cases there is far less information for PFAS-free alternatives compared to the PFAS-based products.19 A lack of information on alternatives does not imply that a regrettable substitution will occur, but it does increase the possibility. It is the responsibility of product manufacturers, in the EU at least, to assess their products before putting them on the market and this could be substantially improved if they better inform scientists and the public of the chemical content of their products so that proper chemical assessments can be undertaken and regrettable substitutions avoided. However, while some substitutions were made purely because effects were unknown at the time, others may have occurred due to a lack of due diligence – where for instance effects of endocrine disruptions were well known, but not tested for. With the inclusion of more hazard endpoints (e.g. endocrine disruption, neurotoxicity, immunotoxicity, respiratory toxicity, sensitisation and terrestrial ecotoxicity) and intrinsic properties (e.g. mobility) as properties of substances of concern under the EU's Chemicals Strategy for Sustainability, the aim is to decrease the likelihood of such regrettable substitutions in the future.
Much work is already underway, in particular by academic and regulatory scientists, to determine how the approach can be implemented in practice. The action plan of the European Commission's Chemicals Strategy for Sustainability2 indicates, for example, that the criteria for essential uses will be defined in the period 2021-22. In this article, the responses to common questions have demonstrated that many of the challenges for the further implementation of the concept are not insurmountable. Despite the criticisms of the concept that have been conveyed, largely by manufacturers of chemicals at risk of being phased out, essentiality of uses as a concept is feasible. Appropriate application of the essential-use concept will furthermore require more information and transparency regarding the uses of chemicals in society, which is a positive development.
This journal is © The Royal Society of Chemistry 2021 |